Physician profile
Shoshana B Craig
NPI 1417927963
$1,130.24
in general payments reported to CMS, 2019-2025
9 companies · $379 in 2025
The $379 reported for 2025 was more than what 78% of Vision Therapy providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $118 · 2022: $125 · 2023: $120 · 2024: $388 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $150.00 | 2025 | Dextenza |
| Rxsight INC | $146.76 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Lkc Technologies, INC. | $139.16 | 2025 | |
| Abbvie INC. | $124.59 | 2022 | |
| Bausch & Lomb Americas INC. | $123.82 | 2024 | Xiidra, Miebo |
| Oyster Point Pharma, INC. | $120.30 | 2023 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $118.39 | 2021 | |
| Amgen INC. | $117.56 | 2024 | Tepezza |
| Coopervision INC. | $89.66 | 2025 | Paragon Crt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shoshana Craig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.